{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T15:11:58Z","timestamp":1790435518814,"version":"4.1.0"},"reference-count":28,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2017,8,10]],"date-time":"2017-08-10T00:00:00Z","timestamp":1502323200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2017,8,10]],"date-time":"2017-08-10T00:00:00Z","timestamp":1502323200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"name":"Northwestern University Clinical and Translational Science Institute"},{"name":"National Center for Advancing Translational Sciences, Clinical and Translational Sciences Award","award":["UL1TR000150"],"award-info":[{"award-number":["UL1TR000150"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dermatologic Therapy"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1111\/dth.12529","type":"journal-article","created":{"date-parts":[[2017,8,10]],"date-time":"2017-08-10T11:56:38Z","timestamp":1502366198000},"page":"e12529","source":"Crossref","is-referenced-by-count":10,"title":["Rate of serious infection in patients who are prescribed systemic biologic or nonbiologic agents for psoriasis: A large, single center, retrospective, observational cohort study"],"prefix":"10.1155","volume":"30","author":[{"given":"Chantelle","family":"Carneiro","sequence":"first","affiliation":[{"name":"Department of Dermatology; Feinberg School of Medicine, Northwestern University; Chicago Illinois"},{"name":"Department of Internal Medicine; Cleveland Clinic; Cleveland Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romi","family":"Bloom","sequence":"additional","affiliation":[{"name":"Department of Dermatology; Feinberg School of Medicine, Northwestern University; Chicago Illinois"},{"name":"NorthShore University Health System; Evanston Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"Ibler","sequence":"additional","affiliation":[{"name":"Department of Dermatology; Feinberg School of Medicine, Northwestern University; Chicago Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Majewski","sequence":"additional","affiliation":[{"name":"Department of Dermatology; Feinberg School of Medicine, Northwestern University; Chicago Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly A.","family":"Sable","sequence":"additional","affiliation":[{"name":"Department of Dermatology; Feinberg School of Medicine, Northwestern University; Chicago Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas J.","family":"Guido","sequence":"additional","affiliation":[{"name":"Department of Dermatology; Feinberg School of Medicine, Northwestern University; Chicago Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Day","sequence":"additional","affiliation":[{"name":"Department of Dermatology; Feinberg School of Medicine, Northwestern University; Chicago Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Nocadello","sequence":"additional","affiliation":[{"name":"Center for Structural Genomics of Infectious Diseases, Feinberg School of Medicine; Northwestern University; Chicago Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra G.","family":"Florek","sequence":"additional","affiliation":[{"name":"Department of Dermatology; Feinberg School of Medicine, Northwestern University; Chicago Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis P.","family":"West","sequence":"additional","affiliation":[{"name":"Department of Dermatology; Feinberg School of Medicine, Northwestern University; Chicago Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1509-3791","authenticated-orcid":false,"given":"Beatrice","family":"Nardone","sequence":"additional","affiliation":[{"name":"Department of Dermatology; Feinberg School of Medicine, Northwestern University; Chicago Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,8,10]]},"reference":[{"key":"10.1111\/dth.12529-BIB0001|dth12529-cit-0002","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1136\/annrheumdis-2013-203407","article-title":"Non-viral opportunistic infections in new users of tumour necrosis factor inhibitor therapy: Results of the SAfety Assessment of Biologic ThERapy (SABER) study","volume":"73","author":"Baddley","year":"2014","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1111\/dth.12529-BIB0002|dth12529-cit-0003","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1001\/jamadermatol.2015.36","article-title":"Adverse event reporting in clinical trials of finasteride for androgenic alopecia: A meta-analysis","volume":"151","author":"Belknap","year":"2015","journal-title":"JAMA Dermatology"},{"key":"10.1111\/dth.12529-BIB0003|dth12529-cit-0004","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/j.rmed.2014.04.017","article-title":"Legionellosis and biologic therapies","volume":"108","author":"Bodro","year":"2014","journal-title":"Respiratory Medicine"},{"key":"10.1111\/dth.12529-BIB0004|dth12529-cit-0005","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0140-6736(14)61909-7","article-title":"Psoriasis","volume":"386","author":"Boehncke","year":"2015","journal-title":"Lancet"},{"key":"10.1111\/dth.12529-BIB0005|dth12529-cit-0006","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1001\/jama.295.19.2275","article-title":"Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: Systematic review and meta-analysis of rare harmful effects in randomized controlled trials","volume":"295","author":"Bongartz","year":"2006","journal-title":"JAMA"},{"key":"10.1111\/dth.12529-BIB0006|dth12529-cit-0007","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.semarthrit.2008.10.002","article-title":"The risk of infections with biologic therapies for rheumatoid arthritis","volume":"39","author":"Furst","year":"2010","journal-title":"Seminars in Arthritis and Rheumatism"},{"key":"10.1111\/dth.12529-BIB0007|dth12529-cit-0008","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1001\/archdermatol.2011.2768","article-title":"Risk of serious adverse events associated with biologic and nonbiologic psoriasis systemic therapy: Patients ineligible vs eligible for randomized controlled trials","volume":"148","author":"Garcia-Doval","year":"2012","journal-title":"Archives of Dermatology"},{"key":"10.1111\/dth.12529-BIB0008|dth12529-cit-0009","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.jaad.2016.07.039","article-title":"Risk of serious infections, cutaneous bacterial infections, and granulomatous infections in patients with psoriasis treated with anti-tumor necrosis factor agents versus classic therapies: Prospective meta-analysis of Psonet registries","volume":"76","author":"Garcia-Doval","year":"2017","journal-title":"Journal of the American Academy of Dermatology"},{"key":"10.1111\/dth.12529-BIB0009|dth12529-cit-0010","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/bjd.14776","article-title":"Should tumour necrosis factor antagonist safety information be applied from patients with rheumatoid arthritis to psoriasis? Rates of serious adverse events in the prospective rheumatoid arthritis BIOBADASER and psoriasis BIOBADADERM cohorts","volume":"176","author":"Garcia-Doval","year":"2017","journal-title":"The British Journal of Dermatology"},{"key":"10.1111\/dth.12529-BIB0010|dth12529-cit-0011","doi-asserted-by":"crossref","first-page":"67","DOI":"10.2340\/00015555-1193","article-title":"Patients with psoriasis feel stigmatized","volume":"92","author":"Hrehorow","year":"2012","journal-title":"Acta Dermato-Venereologica"},{"key":"10.1111\/dth.12529-BIB0011|dth12529-cit-0012","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1111\/jdv.12508","article-title":"The risk of deep fungal infections during biologic therapy for psoriasis","volume":"28","author":"Jourabchi","year":"2014","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"key":"10.1111\/dth.12529-BIB0012|dth12529-cit-0013","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1001\/jamadermatol.2015.0718","article-title":"Risk of serious infection with biologic and systemic treatment of psoriasis: Results from the psoriasis longitudinal assessment and registry (PSOLAR)","volume":"151","author":"Kalb","year":"2015","journal-title":"JAMA Dermatology"},{"key":"10.1111\/dth.12529-BIB0013|dth12529-cit-0014","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jaad.2015.04.023","article-title":"Adverse events resulting in withdrawal of biologic therapy for psoriasis in real-world clinical practice: A Canadian multicenter retrospective study","volume":"73","author":"Kim","year":"2015","journal-title":"Journal of the American Academy of Dermatology"},{"key":"10.1111\/dth.12529-BIB0014|dth12529-cit-0015","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jaad.2014.08.050","article-title":"OBSERVE-5: Observational postmarketing safety surveillance registry of etanercept for the treatment of psoriasis final 5-year results","volume":"72","author":"Kimball","year":"2015","journal-title":"Journal of the American Academy of Dermatology"},{"key":"10.1111\/dth.12529-BIB0015|dth12529-cit-0016","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1111\/bjd.14068","article-title":"Cohort study of malignancies and hospitalized infectious events in treated and untreated patients with psoriasis and a general population in the United States","volume":"173","author":"Kimball","year":"2015","journal-title":"The British Journal of Dermatology"},{"key":"10.1111\/dth.12529-BIB0016|dth12529-cit-0017","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1136\/ard.2008.091025","article-title":"The safety of anti-tumour necrosis factor treatments in rheumatoid arthritis: Meta and exposure-adjusted pooled analyses of serious adverse events","volume":"68","author":"Leombruno","year":"2009","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1111\/dth.12529-BIB0017|dth12529-cit-0018","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.jaad.2008.02.039","article-title":"Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics","volume":"58","author":"Menter","year":"2008","journal-title":"Journal of the American Academy of Dermatology"},{"key":"10.1111\/dth.12529-BIB0018|dth12529-cit-0019","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1001\/archdermatol.2009.188","article-title":"The misperception that clinical trial data reflect long-term drug safety: Lessons learned from Efalizumab's withdrawal","volume":"145","author":"Nijsten","year":"2009","journal-title":"Archives of Dermatology"},{"key":"10.1111\/dth.12529-BIB0019|dth12529-cit-0020","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.cgh.2008.03.014","article-title":"Efficacy and safety of tumor necrosis factor antagonists in Crohn's disease: Meta-analysis of placebo-controlled trials","volume":"6","author":"Peyrin-Biroulet","year":"2008","journal-title":"Clinical Gastroenterology and Hepatology"},{"key":"10.1111\/dth.12529-BIB0020|dth12529-cit-0021","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/s00403-015-1593-8","article-title":"Drug safety of systemic treatments for psoriasis: Results from The German Psoriasis Registry PsoBest","volume":"307","author":"Reich","year":"2015","journal-title":"Archives of Dermatological Research"},{"issue":"Suppl 3","key":"10.1111\/dth.12529-BIB0021|dth12529-cit-0022","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2133.2012.11208.x","article-title":"Long-term safety of biologics in the treatment of moderate-to-severe plaque psoriasis: Review of current data","volume":"167","author":"Rustin","year":"2012","journal-title":"The British Journal of Dermatology"},{"key":"10.1111\/dth.12529-BIB0022|dth12529-cit-0023","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.ad.2015.01.010","article-title":"Risk of reactivation of hepatitis B virus infection in psoriasis patients treated with biologics: A retrospective analysis of 20 cases from the BIOBADADERM database","volume":"106","author":"Sanz-Bueno","year":"2015","journal-title":"Actas Dermo-Sifiliograficas"},{"key":"10.1111\/dth.12529-BIB0023|dth12529-cit-0024","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/cts.12294","article-title":"Enabling a learning health system through a unified enterprise data warehouse: The experience of the Northwestern University Clinical and Translational Sciences (NUCATS) Institute","volume":"8","author":"Starren","year":"2015","journal-title":"Clinical and Translational Science"},{"key":"10.1111\/dth.12529-BIB0024|dth12529-cit-0025","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/ejp.768","article-title":"Pruritus in psoriasis: An update","volume":"20","author":"Szepietowski","year":"2016","journal-title":"European Journal of Pain"},{"key":"10.1111\/dth.12529-BIB0025|dth12529-cit-0026","first-page":"e41","article-title":"Infections associated with the use of tumor necrosis factor-alpha inhibitors in psoriasis","volume":"12","author":"Tan","year":"2013","journal-title":"Journal of Drugs in Dermatology"},{"key":"10.1111\/dth.12529-BIB0026|dth12529-cit-0027","doi-asserted-by":"crossref","DOI":"10.1007\/3-7643-7438-1","volume-title":"TNF-alpha inhibitors","author":"Weinberg","year":"2006"},{"key":"10.1111\/dth.12529-BIB0027|dth12529-cit-0028","first-page":"3156","article-title":"Efficacy and safety of secukinumab in the treatment of moderate to severe plaque psoriasis: A meta-analysis of randomized controlled trials","volume":"8","author":"Xiong","year":"2015","journal-title":"International Journal of Clinical and Experimental Medicine"},{"key":"10.1111\/dth.12529-BIB0028|dth12529-cit-0029","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1136\/annrheumdis-2013-204011","article-title":"Risk of hospitalised infection in rheumatoid arthritis patients receiving biologics following a previous infection while on treatment with anti-TNF therapy","volume":"74","author":"Yun","year":"2015","journal-title":"Annals of the Rheumatic Diseases"}],"container-title":["Dermatologic Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fdth.12529","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/dth.12529\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T17:56:59Z","timestamp":1671818219000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/dth.12529"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,10]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,9]]}},"URL":"https:\/\/doi.org\/10.1111\/dth.12529","archive":["Portico"],"relation":{},"ISSN":["1396-0296"],"issn-type":[{"value":"1396-0296","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8,10]]}}}